Medicare Enrolled

Dr. Jarrod Holmes, MD

Hematology & Oncology · Santa Rosa, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3555 ROUND BARN CIR, Santa Rosa, CA 95403
7075281050
In practice since 2006 (19 years)
NPI: 1013018035 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Holmes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Holmes? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holmes

Dr. Jarrod Holmes is a hematology & oncology specialist in Santa Rosa, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Holmes performed 1,804 Medicare services across 983 unique beneficiaries.

Between the years covered by Open Payments, Dr. Holmes received a total of $212,763 from 57 pharmaceutical and/or device companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holmes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 41% volume in CA $212,763 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,804
Medicare services
Top 41% in CA for hematology & oncology
983
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~95 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
679 $101 $345
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
544 $145 $485
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
214 $69 $245
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
112 $100 $345
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
92 $99 $266
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
37 $43 $154
New patient office visit, complex (60-74 min) 36 $172 $591
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
34 $71 $245
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $128 $447
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
14 $27 $86
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
13 $144 $514
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$212,763
Total received (2018-2024)
Avg $30,395/year across 7 years
Top 5% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
513
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$164,469 (77.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$42,986 (20.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,308 (2.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$48,272
2023
$78,865
2022
$55,890
2021
$4,019
2020
$436
2019
$13,853
2018
$11,427

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$34,600
ABBVIE INC.
$4,580
ADC Therapeutics America, Inc.
$2,400
Janssen Scientific Affairs, LLC
$2,055
BeiGene USA, Inc.
$1,950
TerSera Therapeutics LLC
$1,886
Janssen Biotech, Inc.
$295
Daiichi Sankyo Inc.
$147
SANOFI-AVENTIS U.S. LLC
$99
Lilly USA, LLC
$88
PFIZER INC.
$34
Merck Sharp & Dohme LLC
$32
Novartis Pharmaceuticals Corporation
$30
AstraZeneca Pharmaceuticals LP
$28
Genentech USA, Inc.
$24
Genmab U.S., Inc.
$23
Top 3 companies account for 86.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$71,274
Janssen Biotech, Inc.
$55,623
Pharmacyclics LLC, An AbbVie Company
$28,510
Amgen Inc.
$12,691
AstraZeneca Pharmaceuticals LP
$10,919
ABBVIE INC.
$4,580
TerSera Therapeutics LLC
$4,255
Novartis Pharmaceuticals Corporation
$4,013
BeiGene USA, Inc.
$3,575
Pharmacyclics LLC, an AbbVie Company
$3,159
PFIZER INC.
$2,612
ADC Therapeutics America, Inc.
$2,433
Janssen Scientific Affairs, LLC
$2,055
Kite Pharma, Inc.
$1,731
Seattle Genetics, Inc.
$1,710
E.R. Squibb & Sons, L.L.C.
$437
Merck Sharp & Dohme Corporation
$358
Lilly USA, LLC
$299
GENZYME CORPORATION
$258
Celgene Corporation
$226
Bayer HealthCare Pharmaceuticals Inc.
$197
Eisai Inc.
$179
Seagen Inc.
$174
Daiichi Sankyo Inc.
$170
Astellas Pharma US Inc
$107
SANOFI-AVENTIS U.S. LLC
$99
Exelixis Inc.
$82
Genentech USA, Inc.
$80
Rigel Pharmaceuticals, Inc.
$66
Gilead Sciences, Inc.
$62
Foundation Medicine, Inc.
$61
Regeneron Healthcare Solutions, Inc.
$61
Ipsen Biopharmaceuticals, Inc
$55
Merck Sharp & Dohme LLC
$53
EMD Serono, Inc.
$52
Myovant Sciences Inc.
$49
Taiho Oncology, Inc.
$45
Incyte Corporation
$44
Alexion Pharmaceuticals, Inc.
$41
Janssen Pharmaceuticals, Inc
$38
EISAI INC.
$32
Deciphera Pharmaceuticals Inc.
$30
ARRAY BIOPHARMA INC
$27
JAZZ PHARMACEUTICALS INC.
$23
Genmab U.S., Inc.
$23
Agios Pharmaceuticals, Inc.
$20
AMAG Pharmaceuticals, Inc.
$19
AbbVie, Inc.
$18
Epizyme, Inc.,
$17
Karyopharm Therapeutics Inc.
$17
AbbVie Inc.
$16
Kyowa Kirin, Inc.
$15
Clovis Oncology, Inc.
$15
Jazz Pharmaceuticals Inc.
$15
Organon LLC
$15
Mirati Therapeutics, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$12
Top 3 companies account for 73.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · Abraxane · Aliqopa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · FERAHEME · FOUNDATIONONE · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MOVANTIK · MYLOTARG · NINLARO · Nplate · Nubeqa · OJJAARA · ONTRUZANT · OPDIVO · ORGOVYX · PADCEV · POTELIGEO · Pomalyst · QINLOCK · QUZYTTIR · Quzyttir · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · Stivarga · TAGRISSO · TALVEY · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecartus · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vitrakvi · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for hematology & oncology in CA.

Looking for a hematology & oncology specialist in Santa Rosa?
Compare hematology & oncology specialists in the Santa Rosa area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
11
Per 100K population
2.3
County median income
$102,840
Nearest hospital
SUTTER SANTA ROSA REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Holmes is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Holmes experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Holmes performed 679 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Holmes receive payments from pharmaceutical companies?
Yes. Dr. Holmes received a total of $212,763 from 57 companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Holmes's costs compare to other hematology & oncology specialists in Santa Rosa?
Dr. Holmes's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Holmes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →